N@N

VASC, LANC, THRX, ACET, EK, CYTK Expected to Trade Up After Bullish Patterns Develop

September 26, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top technical trading patterns and these stocks are the most likely to trade Up in the coming weeks. VASCULAR SOLUTIONS, INC. (NASDAQ:VASC), LANCASTER COLONY CORP (NASDAQ:LANC), THERAVANCE INC (NASDAQ:THRX), ACETO CORP (NASDAQ:ACET), EASTMAN KODAK CO (NYSE:EK), CYTOKINETICS INC (NASDAQ:CYTK) are all expected to go Up as Bullish signals have been generated by top technical trading patterns. We monitor these patterns: Support Break, Support Reversal, Breakaway Gap, Measured Gap, Exhaustion Gap, Resistance Break, Resistance Reversal, Saucer Reversal, Volume Climax, Volume Trend, Fibonacci Reversal, Consolidation Breaks, Trend Line Break,Trend Line Reversal, Candles, Golden Crosses, Death Crosses and more. The chart below displays the stocks expected to go Up along with pattern, strategy and strength ratings.

     Symbol     Company                             Strategy                            Pattern Name            Strength  
     VASC       VASCULAR SOLUTIONS, INC.            Reversal (Stocks) DWC               Trend Line Reversal(5+)     3         
     LANC       LANCASTER COLONY CORP               VWAP Bounce EOD                     Trend Line Break(2)     3         
     THRX       THERAVANCE INC                      Breakout (Stocks) DO                Trend Line Break(2)     4         
     ACET       ACETO CORP                          Reversal (Stocks) DWC               Trend Line Break(5+)     5         
     EK         EASTMAN KODAK CO                    Breakout (Stocks) DO (+1)           Harami                  5         
     CYTK       CYTOKINETICS INC                    Breakout (Stocks) DO                Trend Line Reversal(3)     4         

Chart Pattern Recognition is based on a 20-year patterns database. This database is used to determine pattern strength for patterns as they appear. There is no optimization and the pattern signals never change. For each pattern variation, we record accuracy and profitability statistics in a patterns database. From this information, we are able to define strength ratings from 1 to 5. The '1' rating shows ALL patterns while a '5' rating shows the best patterns according to profitability. Each pattern has its own strength rating factors. The result is an automatic ranking system that allows us to only show the BEST patterns. You can see that, at Strength 5, virtually all the patterns are profitable. The pattern strength rating system separates the most profitable patterns. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php

VASCULAR SOLUTIONS, INC. (NASDAQ:VASC) - Vascular Solutions, Inc., a medical device company, develops solutions to interventional cardiologists and interventional radiologists worldwide. It provides Hemostat products, including D-Stat Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding; and D-Stat Flowable hemostat, a thick yet flowable thrombin-based mixture for preventing bleeding in subcutaneous pockets. The company also offers extraction catheters consisting of the Pronto V3 and Pronto LP extraction catheters and mechanical systems for the removal of soft thrombus from arteries; vein products, including Vari-Lase endovenous laser, a laser and procedure kit that is used for the treatment of varicose veins; and specialty catheters, such as Langston dual lumen catheters, Twin-Pass dual access catheters, GuideLiner catheters, Minnie support catheters, and Gopher catheters. In addition, it provides access products, which include Micro Elite and Expro Elite snares, the Guardian hemostasis valve, and guidewires used in connection with percutaneous access to the vasculature. Further, the company offers Acolysis ultrasound thrombolysis system for the treatment of peripheral vascular diseases in the international markets. Vascular Solutions, Inc. offers its products directly to the physicians through direct domestic sales force and international distribution network. The company was founded in 1996 and is based in Minneapolis, Minnesota.

LANCASTER COLONY CORP (NASDAQ:LANC) - Lancaster Colony Corporation engages in the manufacture and marketing of consumer products in the United States. The company operates in two segments: Specialty Foods, and Glassware and Candles. The Specialty Foods segment produces and sells food products, including salad dressings and sauces under the Marzetti, T. Marzetti, Cardinis, Pfeiffer, and Girards brands; fruit glazes, and vegetable and fruit dips under the T. Marzetti brand; frozen breads under the New York BRAND and Mamma Bella brands; frozen Parkerhouse style yeast dinner rolls and sweet rolls, as well as biscuits under the Sister Schuberts, Marshalls, and Mary Bs brands; dry egg noodles under the Inn Maid and Amish Kitchen brands; frozen specialty noodles and pastas under the Reames and Aunt Vis brands; croutons and related products under New York BRAND, Texas Toast, Chatham Village, Cardinis, and T. Marzetti brands; and caviar under the Romanoff brand. This segment markets its products through sales personnel, food brokers, and distributors to retail, club store, foodservice, and industrial markets. The Glassware and Candles segment engages in the manufacture and marketing of candles for the food, drug, and mass markets; and distribution of various products, including glassware and candles, candle accessories, and other home fragrance products in various sizes, forms, and fragrances to mass merchants, supermarkets, drug stores, and specialty shops, as well as to commercial markets, including restaurants, hotels, hospitals, and schools under the Candle-lite brand name. The company was founded in 1961 and is based in Columbus, Ohio.

THERAVANCE INC (NASDAQ:THRX) - Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines across various therapeutic areas, including respiratory disease, bacterial infections, and gastrointestinal motility dysfunction. Its key programs include VIBATIV with Astellas Pharma, Inc. approved in the United States and Canada for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant and methicillin-susceptible strains; RELOVAIR with GlaxoSmithKline (GSK), a Phase 3 clinical trial program for the treatment of patients with chronic obstructive pulmonary disease and/or asthma; and the Bifunctional Muscarinic Antagonist-beta2 Agonist program with GSK, which completed Phase 2a. The companys other pipeline programs under various clinical-stages comprise TD-1211, an oral peripheral Mu-opioid antagonist for the treatment of opioid-induced constipation; TD-5108 and TD-8954, 5HT-4 agonists for the treatment of gastrointestinal motility dysfunction and/or Alzheimers disease; TD-1792, an antibiotic for the treatment of serious infections caused by Gram-positive bacteria; and MARIN program (TD-9855) for the treatment of chronic pain. The company was formerly known as Advanced Medicine, Inc. and changed its name to Theravance, Inc. in April 2002. Theravance was founded in 1996 and is headquartered in South San Francisco, California.

ACETO CORP (NASDAQ:ACET) - Aceto Corporation, together with its subsidiaries, engages in sourcing, quality assurance, regulatory support, marketing, and distributing chemically derived pharmaceuticals, biopharmaceuticals, specialty chemicals, and crop protection products. It operates in three segments: Health Sciences, Chemicals and Colorants, and Crop Protection. The Health Sciences segment offers active ingredients for generic pharmaceuticals, vitamins, and nutritional supplements, as well as products used in preparing pharmaceuticals primarily by drug companies and biopharmaceuticals. The Chemicals and Colorants segment offers specialty chemicals used in plastics, resins, adhesives, coatings, food, flavor additives, fragrances, cosmetics, metal finishing, electronics, and air-conditioning systems. This segments products include dye and pigment intermediates, which are used in the color-producing industries, such as textiles, inks, paper, and coatings; and organic intermediates used in the production of agrochemicals. The Crop Protection segment provides herbicides, fungicides, and insecticides that control weed growth, as well as control the spread of insects and other micro organisms that damage plant growth. This segment also offers a sprout inhibitor for potatoes and an herbicide for sugar cane. Aceto Corporation serves a range of companies in the pharmaceutical, agricultural, color, surface coating/ink, general chemical consuming, and health science industries in the United States, Europe, and the Asia-Pacific. The company was founded in 1947 and is headquartered in Lake Success, New York.

EASTMAN KODAK CO (NYSE:EK) - Eastman Kodak Company provides imaging technology products and services to the photographic and graphic communications markets worldwide. It operates in three segments: Consumer Digital Imaging Group (CDG); Film, Photofinishing, and Entertainment Group (FPEG); and Graphic Communications Group (GCG). The CDG segment offers consumer digital capture and devices, including digital still and pocket video cameras, digital picture frames, imaging essentials, accessories, memory products, snapshot printers and related media; retail kiosks and consumables, consumer and retailer software workflows, remote business monitoring, retail store merchandising and identity programs, and after sale service and support; imaging sensors; and all-in-one inkjet printers. It also provides online merchandise and sharing services. The FPEG segment comprises traditional photographic products and services, including paper, film, and chemistry used for consumer, professional, and industrial imaging applications, as well as those products and services used in the creation of motion pictures. It manufactures and markets motion picture, consumer, professional, industrial, and aerial films; one-time-use cameras; photographic paper and photo chemicals; and industrial components. The GCG segment provides digital and traditional prepress equipment and consumables, including plates, chemistry, and media; workflow software and digital controller development; color, and black and white electrophotographic equipment and consumables; commercial inkjet printing systems; production and workgroup document scanners; and micrographic peripherals and media. It also provides imaging services; and maintenance and professional services for other manufacturers products. This segment serves various customers in the creative, in-plant, data center, commercial printing, packaging, newspaper, and digital service bureau market segments. The company was founded in 1880 and is headquartered in Rochester, New York.

CYTOKINETICS INC (NASDAQ:CYTK) - Cytokinetics, Incorporated, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. It primarily offers omecamtiv mecarbil, a cardiac muscle myosin activator, which is in Phase I/IIa clinical trials for the treatment of heart failure; CK-2017357, which is a Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis; and CK-2066260, a fast skeletal muscle sarcomere activator for the treatment of diseases and conditions associated with muscle weakness or wasting. The companys cancer treatment products under development stage comprise ispinesib, SB-743921, and GSK-923295. It has a strategic alliance with Amgen Inc. to discover, develop, and commercialize novel small molecule therapeutics that activate cardiac muscle contractility for applications in the treatment of heart failure. The company was founded in 1997 and is headquartered in South San Francisco, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net